Can Discrete Choice Experiment Technique Predict Real-World Healthcare Decisions?

Published Sep 23, 2019

New Research Provides External Validation in Choices for Influenza Vaccination or Colorectal Cancer Screening

Lawrenceville, NJ, USA—September 23, 2019—Value in Health, the official journal of ISPOR—the professional society for health economics and outcomes research, announced today the publication of research demonstrating that discrete choice experiments (DCEs) are able to predict real-world healthcare choices. The report, “Are Healthcare Choices Predictable? The Impact of Discrete Choice Experiment Designs and Models,” was published in the September 2019 issue of Value in Health

The discrete choice experiment technique, originating from mathematical psychology, is mainstream in marketing, transport, and environmental economics, where it is used to predict individual and collective choices. DCEs have also been introduced in health economics, where they are commonly used for valuing health and nonhealth outcomes, investigating trade-offs between health and nonhealth outcomes, and developing priority setting frameworks. Currently, among other barriers, the lack of evidence about the external validity of DCEs inhibits their greater use in healthcare decision making.

Researchers from The Netherlands and Australia sought to determine whether the number of alternatives in a DCE choice task should reflect the actual decision context, and how complex the choice model needs to be to be able to predict real-world healthcare choices. Six DCEs were used, varying with regard to medical condition (influenza vaccination or colorectal cancer screening) and the number of alternatives per choice task. For each medical condition, 1200 respondents were randomized to one of the DCE formats.

At an aggregate level, the choice mimicking a real-world decision to opt for influenza vaccination and colorectal cancer screening was correctly predicted by a DCE-based model, if scale and preference heterogeneity were taken into account. At an individual level, the use of 3 alternatives per choice task and a heteroskedastic error component model seemed to be most promising, correctly predicting in 93.6% and 97.1% of the cases for vaccination and screening, respectively. Five respondent characteristics consistently explained a part of the observed scale and/or preference heterogeneity: sex, numeracy skill (the ability to understand and work with numbers), decision-making style, general attitude toward the health intervention of interest, and experience with the health intervention of interest.

“Our study shows that discrete choice experiments are able to predict choices—mimicking real-world decisions—if at least scale and preference heterogeneity are taken into account,” said author Esther W. de Bekker-Grob, PhD, Erasmus School of Health Policy & Management, Erasmus University Rotterdam, The Netherlands. “While further research is needed to determine whether this result remains in other contexts, we are pleased that our work has contributed to the evidence regarding the external validity of discrete choice experiments in healthcare decision making.”

###

ABOUT ISPOR
ISPOR, the professional society for health economics and outcomes research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field.
Web: www.ispor.org | LinkedIn: www.linkedin.com/company/ispororg | Twitter: www.twitter.com/ispororg (@ISPORorg) | YouTube: www.youtube.com/ispororg | Facebook: www.facebook.com/ispororg | Instagram: www.instagram.com/ispororg

ABOUT VALUE IN HEALTH
Value in Health (ISSN 1098-3015) is an international, indexed journal that publishes original research and health policy articles that advance the field of health economics and outcomes research to help healthcare leaders make evidence-based decisions. The journal’s 2018 impact factor score is 5.037. Value in Health is ranked 4th among 81 journals in health policy and services, 5th among 98 journals in healthcare sciences and services, and 11th among 363 journals in economics. Value in Health is a monthly publication that circulates to more than 10,000 readers around the world.
Web: www.ispor.org/valueinhealth | Twitter: www.twitter.com/isporjournals (@ISPORjournals)

Related Stories

Expert Analysis- Healthcare Value Assessment Frameworks Have Advanced, But Wholesale Adoption Still Not Wise

Sep 23, 2019

Value in Health, the official journal of ISPOR, announced the publication of an analysis showing that while value assessment frameworks are moving closer to meeting the challenge of accurately measuring value and reliably informing healthcare decisions, more progress is needed before widespread adoption and use.

Medicare Part D and the Affordable Care Act Have Shifted Direct Expenditures for Medications from US Consumers to Insurers and Public Payers

Aug 27, 2019

Value in Health, the official journal of ISPOR, announced today the publication of new research showing that while expenditures for prescribed medicines have risen significantly in the United States for the past 2 decades, expanded prescription drug coverage has resulted in a significant reduction in patient out-of-pocket drug costs.

Incorporating Affordability Concerns Within Cost-Effectiveness Analysis for Health Technology Assessment

Aug 27, 2019

Value in Health, the official journal of ISPOR, announced today the publication of a report introducing a new framework by which concerns for affordability can be appropriately incorporated within cost-effectiveness analysis.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×